Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 2/20 | 0.51 |
| ▸ | ANPEP | P15144 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 4/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13836866 | 1.00 | MMP2 (0.51) | MMP2ANPEPHSD17B10CYP1A2POLB | |
| SCHEMBL20705291 | 1.00 | MMP2 (0.51) | MMP2ANPEPHSD17B10CYP1A2POLB | |
| SCHEMBL17859969 | 1.00 | MMP2 (0.51) | MMP2ANPEPHSD17B10CYP1A2POLB | |
| SCHEMBL29071685 | 1.00 | MMP2 (0.51) | MMP2ANPEPHSD17B10CYP1A2POLB | |
| SCHEMBL25594426 | 0.88 | MMP2 (0.41) | MMP2ANPEPHSD17B10CYP1A2POLB | |
| SCHEMBL20789374 | 0.88 | MMP2 (0.41) | MMP2ANPEPHSD17B10CYP1A2POLB | |
| SCHEMBL30476454 | 0.88 | MMP2 (0.50) | MMP2ANPEPHSD17B10CYP1A2POLB | |
| SCHEMBL30685061 | 0.88 | MMP2 (0.50) | MMP2ANPEPHSD17B10CYP1A2POLB | |
| SCHEMBL25257322 | 0.88 | MMP2 (0.41) | MMP2ANPEPHSD17B10CYP1A2POLB | |
| SCHEMBL13494285 | 0.87 | MMP2 (0.70) | MMP2ANPEPCYP1A2POLBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119505138-A | Chiral covalent organic framework mimic enzyme catalyst and preparation method and application thereof | 浙江工业大学 | 2025-02-25 | — | — | CN | claimed |
| CN-119505138-A | Chiral covalent organic framework mimic enzyme catalyst and preparation method and application thereof | 浙江工业大学 | 2025-02-25 | — | — | CN | disclosed |
| US-12180188-B2 | Antifibrotic compounds and related methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| CN-112135830-B | Oxo-substituted compounds | 住友制药株式会社 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023183616-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SENDA BIOSCIENCES, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| US-20230287009-A1 | OXO-SUBSTITUTED COMPOUND | Sumitomo Pharma Co., Ltd. (JP) | 2023-09-14 | — | — | US | disclosed |
| US-11702431-B2 | Oxo-substituted compound | Sumitomo Pharma Co., Ltd. (JP) | 2023-07-18 | — | — | US | disclosed |
| EP-4153177-A1 | ANTIFIBROTIC COMPOUNDS AND RELATED METHODS | Florida State University Research Foundation, Inc. (US) | 2023-03-29 | — | — | EP | disclosed |
| US-20230090542-A1 | Antifibrotic Compounds And Related Methods | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES | 2023-03-23 | — | — | US | disclosed |
| US-11548874-B2 | Antifibrotic compounds and related methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-11066425-B1 | Oxo-substituted compound | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2021-07-20 | — | — | US | disclosed |
| US-20210147448-A1 | OXO-SUBSTITUTED COMPOUND | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2021-05-20 | — | — | US | disclosed |
| EP-3786168-A1 | OXO-SUBSTITUTED COMPOUND | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2021-03-03 | — | — | EP | disclosed |
| CN-112135830-A | Oxo substituted compounds | 大日本住友制药株式会社 | 2020-12-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702431-B2 | Oxo-substituted compound | CYP51A1, OXA1L, O60361 | MMP2 122/4885ANPEP 238/4885HSD17B10 306/4885 |
| US-11066425-B1 | Oxo-substituted compound | CYP51A1, OXA1L, O60361 | MMP2 122/4885ANPEP 238/4885HSD17B10 306/4885 |
| US-20210147448-A1 | OXO-SUBSTITUTED COMPOUND | CYP51A1, OXA1L, O60361 | MMP2 122/4885ANPEP 238/4885HSD17B10 306/4885 |
| US-11548874-B2 | Antifibrotic compounds and related methods | COL1A1, COL2A1, COLGALT1 | MMP2 29/4885ANPEP 1627/4885HSD17B10 691/4885 |
| US-12180188-B2 | Antifibrotic compounds and related methods | COL1A1, COL2A1, COLGALT1 | MMP2 29/4885ANPEP 1627/4885HSD17B10 691/4885 |
| US-20230090542-A1 | Antifibrotic Compounds And Related Methods | COL1A1, COL2A1, COLGALT1 | MMP2 29/4885ANPEP 1627/4885HSD17B10 691/4885 |
| US-20230287009-A1 | OXO-SUBSTITUTED COMPOUND | CYP51A1, OXA1L, O60361 | MMP2 122/4885ANPEP 238/4885HSD17B10 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.